DECISION OF THE EEA JOINT COMMITTEE No 60/2025

of 14 March 2025

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2025/983]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

(1) Commission Implementing Regulation (EU) 2024/1280 of 30 April 2024 amending Implementing Regulation (EU) No 540/2011 as regards the approval periods of the active substances dodemorph, fatty acids C8-C10 methyl esters, lauric acid, methyl octanoate, methyl decanoate, oleic acid and Trichoderma atroviride (formerly T. harzianum ) strain IMI 206040 ( 1 ) is to be incorporated into the EEA Agreement.

(2) Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following indent is added in point 13a (Commission Implementing Regulation (EU) No 540/2011) of Chapter XV of Annex II to the EEA Agreement:

‘—

32024 R 1280 : Commission Implementing Regulation (EU) 2024/1280 of 30 April 2024 ( OJ L, 2024/1280, 3.5.2024 ).’

Article 2

The text of Implementing Regulation (EU) 2024/1280 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union , shall be authentic.

Article 3

This Decision shall enter into force on 15 March 2025, provided that all the notifications under Article 103(1) of the EEA Agreement have been made ( *1 ) .

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union .

Done at Brussels, 14 March 2025.

For the EEA Joint Committee

The President

Nicolas VON LINGEN

( 1 ) OJ L, 2024/1280, 3.5.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/1280/oj .

( *1 ) No constitutional requirements indicated.

ELI: http://data.europa.eu/eli/dec/2025/983/oj

ISSN 1977-0677 (electronic edition)